Clinical trials - Press Releases

Date	Title	Company
22-Apr-2021	Pharming announces enrolment of first patient in multicentre Phase IIb clinical trial of RUCONEST® for the prevention of acute kidney injury after myocardial infarction	Pharming Group N.V.
22-Apr-2021	Lipidor – update on the company’s phase III clinical trial of drug candidate AKP02 for treatment of psoriasis	Lipidor AB
21-Apr-2021	Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study	Lilly
21-Apr-2021	Jazz Pharmaceuticals Presents Phase 3 Study Results of Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic Hypersomnia at 2021 American Academy of Neurology Annual Meeting	Jazz Pharmaceuticals
21-Apr-2021	Evelo Biosciences Presents Further Positive Data from Phase 1b Clinical Trial of EDP1815 in Atopic Dermatitis	Evelo Biosciences
21-Apr-2021	STEMart Announces Medical Device Design Services for the Biomedical Industry	STEMart
21-Apr-2021	CD Bioparticles Introduces Lipid Nanoparticle Formulation and Development for mRNA Vaccine Delivery	CD Bioparticles
20-Apr-2021	Janssen Provides Update on Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) Plus Prednisone Combination	Janssen
16-Apr-2021	Clinerion adds Patient Network Explorer coverage to four new hospitals in Brazil, bringing the total to 17 hospitals and over 7 million patients.	Clinerion Ltd.
16-Apr-2021	Amplia Completes Dosing in Phase 1 Clinical Study of AMP945	Amplia Therapeutics
16-Apr-2021	PharmiWeb.Jobs Welcomes Astellas	Astellas
16-Apr-2021	PharmiWeb.Jobs Welcomes Medical Developments International	Medical Developments International
16-Apr-2021	New data for Roche’s OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis	Roche
16-Apr-2021	Roche’s Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)	Roche
16-Apr-2021	Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19	Merck
15-Apr-2021	Top 10 Reasons to join SMi's 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference	SMi Group
15-Apr-2021	Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations	Novavax
14-Apr-2021	Hope for poorer nations as a food staple, sodium-bicarbonate was found in a peer-reviewed study to significantly reduce Covid symptoms	Copper Clothing
14-Apr-2021	Tagrisso is the only targeted medicine to show efficacy in the treatment of early-stage lung cancer in a global trial and the first such medicine approved in China	AstraZeneca
14-Apr-2021	Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity	Boehringer Ingelheim